<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">35849154</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey.</ArticleTitle><Pagination><StartPage>6003</StartPage><EndPage>6013</EndPage><MedlinePgn>6003-6013</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11273-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">To capture the patient's attitude toward remote monitoring of motor neuron disease (MND) in care and clinical trials, and their concerns and preferences regarding the use of digital technology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed an international multi-centre survey study in three MND clinics in The Netherlands, the United Kingdom, and Australia. The survey was co-developed by investigators and patients with MND, and sent to patients by e-mail or postal-mail. The main topics included: patients' attitude towards remote care, participating in decentralized clinical trials, and preferences for and concerns with digital technology use.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 332 patients with MND participated. A majority of patients indicated they would be happy to self-monitor their health from home (69%), be remotely monitored by a multidisciplinary care team (75%), and would be willing to participate in clinical trials from home (65%). Patients considered respiratory function and muscle strength most valuable for home-monitoring. The majority of patients considered the use of at least three devices/apps (75%) once a week (61%) to be acceptable for home-monitoring. Fifteen percent of patients indicated they would not wish to perform home-measurements; reporting concerns about the burden and distress of home-monitoring, privacy and data security.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Most patients with MND exhibited a positive attitude toward the use of digital technology in both care and clinical trial settings. A subgroup of patients reported concerns with home-monitoring, which should be addressed in order to improve widespread adoption of remote digital technology in clinical MND care.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Helleman</LastName><ForeName>Jochem</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Johnson</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Holdom</LastName><ForeName>Cory</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobson</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Deirdre</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Academic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiotherapy Department, Beaumont Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesley Medical Research, The Wesley Hospital, Auchenflower, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henders</LastName><ForeName>Anjali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lokeshappa</LastName><ForeName>Madhura B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser-Meily</LastName><ForeName>Johanna M A</ForeName><Initials>JMA</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Neuroscience Centre, Beaumont Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beelen</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>McDermott</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>van Eijk</LastName><ForeName>Ruben P A</ForeName><Initials>RPA</Initials><Identifier Source="ORCID">0000-0002-7132-5967</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. r.p.a.vaneijk-2@umcutrecht.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. r.p.a.vaneijk-2@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013672" MajorTopicYN="N">Technology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Digital technology</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Patient perspective</Keyword><Keyword MajorTopicYN="N">Survey</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35849154</ArticleId><ArticleId IdType="pmc">PMC9294855</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11273-x</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11273-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, et al. The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design. Amyotroph Lateral Scler Front Degener. 2018;19(5&#x2013;6):351&#x2013;361. doi: 10.1080/21678421.2018.1440408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1440408</ArticleId><ArticleId IdType="pubmed">29451026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE (2005) Prevalence and patterns of cognitive impairment in sporadic ALS [Internet]. www.neurology.org</Citation><ArticleIdList><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens HE, Young J, Felgoise SH, Simmons Z. A qualitative study of multidisciplinary ALS clinic use in the United States. Amyotroph Lateral Scler Front Degener. 2016;17(1&#x2013;2):55&#x2013;61. doi: 10.3109/21678421.2015.1069851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1069851</ArticleId><ArticleId IdType="pubmed">26508132</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenberg KL, Hansen G. Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics. J Multidiscip Healthc. 2018;11:519&#x2013;524. doi: 10.2147/JMDH.S177563.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S177563</ArticleId><ArticleId IdType="pmc">PMC6171753</ArticleId><ArticleId IdType="pubmed">30319269</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Kruitwagen ET, van den Berg LH, Visser-Meily JMA, Beelen A. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. Amyotroph Lateral Scler Front Degener. 2020;21(3&#x2013;4):167&#x2013;182. doi: 10.1080/21678421.2019.1706581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1706581</ArticleId><ArticleId IdType="pubmed">31878794</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson E, Baird W, Bradburn M, Cooper C, Mawson S, Quinn A, et al. Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre. BMJ Open. 2019;9(10):e028526. doi: 10.1136/bmjopen-2018-028526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028526</ArticleId><ArticleId IdType="pmc">PMC6830641</ArticleId><ArticleId IdType="pubmed">31640994</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Van Eenennaam R, Kruitwagen ET, Kruithof WJ, Slappendel MJ, Van Den Berg LH, et al. Telehealth as part of specialized ALS care: feasibility and user experiences with &#x201c;ALS home-monitoring and coaching&#x201d;. Amyotroph Lateral Scler Front Degener. 2020;21(3&#x2013;4):183&#x2013;192. doi: 10.1080/21678421.2020.1718712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1718712</ArticleId><ArticleId IdType="pubmed">32003245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Qi K, Shelton K, Liss J, Berisha V, Shefner JM. ALS longitudinal studies with frequent data collection at home: study design and baseline data. Amyotroph Lateral Scler Front Degener [Internet]. 2019;20(1&#x2013;2):61&#x2013;67. doi: 10.1080/21678421.2018.1541095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1541095</ArticleId><ArticleId IdType="pmc">PMC6513689</ArticleId><ArticleId IdType="pubmed">30486680</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Bakers JNE, Bunte TM, de Fockert AJ, Eijkemans MJC, van den Berg LH. Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study. J Neurol [Internet]. 2019;266(10):2387&#x2013;2395. doi: 10.1007/s00415-019-09427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09427-5</ArticleId><ArticleId IdType="pmc">PMC6765690</ArticleId><ArticleId IdType="pubmed">31187191</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott CJ. Clinical trials in amyotrophic lateral sclerosis. Curr Opin Neurol. 2019;32(5):758&#x2013;763. doi: 10.1097/WCO.0000000000000731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000731</ArticleId><ArticleId IdType="pubmed">31335338</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen AA, Simpson EP, Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(6):702&#x2013;708. doi: 10.1002/mus.20658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20658</ArticleId><ArticleId IdType="pubmed">16967489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothare PA, Jadhav PR, Gupta P, Harrelson JC, Dickmann L. Harnessing the potential of emerging digital health and biological sampling technologies for clinical drug development: promise to reality. Clin Pharmacol Ther. 2018;104(6):1125&#x2013;1135. doi: 10.1002/cpt.1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1100</ArticleId><ArticleId IdType="pubmed">29696625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Baird WO, Cooper CL, Mawson S, Shaw PJ, Mcdermott CJ. Using technology to improve access to specialist care in amyotrophic lateral sclerosis: a systematic review, Vol. 17, amyotrophic lateral sclerosis and frontotemporal degeneration. New York: Taylor and Francis Ltd; 2016. pp. 313&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">27027466</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotroph Lateral Scler Front Degener [Internet]. 2020;21(7&#x2013;8):542&#x2013;548. doi: 10.1080/21678421.2020.1773502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1773502</ArticleId><ArticleId IdType="pubmed">32530314</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, D&#x2019;Ovidio F, Di Pede F, De Mattei F, Cabras S, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Front Degener [Internet]. 2021;22(3&#x2013;4):308&#x2013;311. doi: 10.1080/21678421.2020.1820043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1820043</ArticleId><ArticleId IdType="pubmed">32924624</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne MD. Telehealth and the COVID-19 pandemic. J Perianesthesia Nurs [Internet]. 2020;35(5):548&#x2013;551. doi: 10.1016/j.jopan.2020.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2020.06.023</ArticleId><ArticleId IdType="pmc">PMC7377686</ArticleId><ArticleId IdType="pubmed">32861582</ArticleId></ArticleIdList></Reference><Reference><Citation>Maese JR, Seminara D, Shah Z, Szerszen A. Perspective: what a difference a disaster makes: the telehealth revolution in the age of COVID-19 pandemic. Am J Med Qual. 2020;35(5):429&#x2013;431. doi: 10.1177/1062860620933587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860620933587</ArticleId><ArticleId IdType="pmc">PMC7290106</ArticleId><ArticleId IdType="pubmed">32525394</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida JPL, Pinto A, Pinto S, Ohana B, De Carvalho M. Economic cost of home-telemonitoring care for BiPAP-assisted ALS individuals. Amyotroph Lateral Scler. 2012;13(6):533&#x2013;537. doi: 10.3109/17482968.2012.703675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.703675</ArticleId><ArticleId IdType="pubmed">22873565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Heal Surveill. 2020;6(2):18810. doi: 10.2196/18810.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18810</ArticleId><ArticleId IdType="pmc">PMC7124951</ArticleId><ArticleId IdType="pubmed">32238336</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Sarnelli MF, Serioli M, De Marchi I, Zani E, Bottone N, et al. Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID-19 pandemic. Acta Neurol Scand. 2021;143(5):489&#x2013;496. doi: 10.1111/ane.13373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13373</ArticleId><ArticleId IdType="pubmed">33185886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Quintarelli S, Silani V. New technologies and amyotrophic lateral sclerosis&#x2014;which step forward rushed by the COVID-19 pandemic? J Neurol Sci [Internet]. 2020;418(May):117081. doi: 10.1016/j.jns.2020.117081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117081</ArticleId><ArticleId IdType="pmc">PMC7403097</ArticleId><ArticleId IdType="pubmed">32882437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombaci A, Abbadessa G, Trojsi F, Leocani L, Bonavita S. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol Sci. 2020;42:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538170</ArticleId><ArticleId IdType="pubmed">33025327</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Beelen A, Kruitwagen ET, Murray D, Radakovic R, Hobson E, et al. A road map for remote digital health technology for motor neuron disease. J Med Internet Res. 2021;23(9):e28766. doi: 10.2196/28766.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28766</ArticleId><ArticleId IdType="pmc">PMC8495582</ArticleId><ArticleId IdType="pubmed">34550089</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito DA, Myers BA, Mc Curry KR, Dunbar-Jacob J, Hawkins RP, Begey A, et al. User-centered design and interactive health technologies for patientsi. CIN - Comput Inform Nurs. 2009;27(3):175&#x2013;183. doi: 10.1097/NCN.0b013e31819f7c7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NCN.0b013e31819f7c7c</ArticleId><ArticleId IdType="pmc">PMC2818536</ArticleId><ArticleId IdType="pubmed">19411947</ArticleId></ArticleIdList></Reference><Reference><Citation>Plahuta JM, McCulloch BJ, Kasarskis EJ, Ross MA, Walter RA, McDonald ER. Amyotrophic lateral sclerosis and hopelessness: psychosocial factors. Soc Sci Med. 2002;55(12):2131&#x2013;2140. doi: 10.1016/S0277-9536(01)00356-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0277-9536(01)00356-2</ArticleId><ArticleId IdType="pubmed">12409126</ArticleId></ArticleIdList></Reference><Reference><Citation>Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Chavannes NH, et al. Home monitoring in patients with idiopathic pulmonary fibrosis: a randomized controlled trial. Am J Respir Crit Care Med. 2020;202(3):393&#x2013;401. doi: 10.1164/rccm.202002-0328OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202002-0328OC</ArticleId><ArticleId IdType="pubmed">32325005</ArticleId></ArticleIdList></Reference><Reference><Citation>Safstrom E, Jaarsma T, Nordgren L, Liljeroos M, Stomberg A. Factors related to perceived continuity of care in hospitalized cardiac patients. Eur Heart J. 2020;41(Supplement_2):3408. doi: 10.1093/ehjci/ehaa946.3408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/ehaa946.3408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Fazal S, Shaw PJ, McDermott CJ. &#x201c;Anything that makes life&#x2019;s journey better.&#x201d; Exploring the use of digital technology by people living with motor neurone disease. Amyotroph Lateral Scler Front Degener. 2017;18(5&#x2013;6):378&#x2013;387. doi: 10.1080/21678421.2017.1288253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1288253</ArticleId><ArticleId IdType="pubmed">28631958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, Narayanaswami P, Berisha V, Liss J, Hahn S, Shelton K, et al. Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept study. Ann Clin Transl Neurol. 2020;7(7):1148&#x2013;1157. doi: 10.1002/acn3.51096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51096</ArticleId><ArticleId IdType="pmc">PMC7359124</ArticleId><ArticleId IdType="pubmed">32515889</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge HH, Zhu J, Mattek NC, Austin D, Kornfeld J, Kaye JA. Use of high-frequency in-home monitoring data may reduce sample sizes needed in clinical trials. PLoS ONE. 2015;10(9):1&#x2013;15. doi: 10.1371/journal.pone.0138095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138095</ArticleId><ArticleId IdType="pmc">PMC4574479</ArticleId><ArticleId IdType="pubmed">26379170</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk RPA, Westeneng HJ, Nikolakopoulos S, Verhagen IE, Van Es MA, Eijkemans MJC, et al. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials. Neurology. 2019;92(5):E451&#x2013;E460. doi: 10.1212/WNL.0000000000006855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006855</ArticleId><ArticleId IdType="pmc">PMC6369899</ArticleId><ArticleId IdType="pubmed">30626653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: Do enrolled patients accurately represent the ALS population? Neurology. 2011;77(15):1432&#x2013;1437. doi: 10.1212/WNL.0b013e318232ab9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318232ab9b</ArticleId><ArticleId IdType="pubmed">21956723</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaja SJ, Charness N, Fisk AD, Hertzog C, Nair SN, Rogers WA, et al. Factors predicting the use of technology: findings from the Center for Research and Education on Aging and Technology Enhancement (CREATE) Psychol Aging. 2006;21(2):333&#x2013;352. doi: 10.1037/0882-7974.21.2.333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.21.2.333</ArticleId><ArticleId IdType="pmc">PMC1524856</ArticleId><ArticleId IdType="pubmed">16768579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta B, Peng MH, Sun SL. Modeling the adoption of personal health record (PHR) among individual: the effect of health-care technology self-efficacy and gender concern. Libyan J Med [Internet]. 2018 doi: 10.1080/19932820.2018.1500349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19932820.2018.1500349</ArticleId><ArticleId IdType="pmc">PMC6060373</ArticleId><ArticleId IdType="pubmed">30037314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleger LE, Guirguis K, Mertes A. Making public concerns tangible: an empirical study of German and UK citizens&#x2019; perception of data protection and data security. Comput Human Behav [Internet]. 2021;122(February 2020):106830. doi: 10.1016/j.chb.2021.106830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chb.2021.106830</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter G, Borzikowsky C, Lesch W, Semler SC, Bunnik EM, Buyx A, et al. Secondary research use of personal medical data: attitudes from patient and population surveys in The Netherlands and Germany. Eur J Hum Genet [Internet]. 2021;29(3):495&#x2013;502. doi: 10.1038/s41431-020-00735-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00735-3</ArticleId><ArticleId IdType="pmc">PMC7940390</ArticleId><ArticleId IdType="pubmed">33005018</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenaway LP, Martin NH, Lawrence V, Janssen A, Al-Chalabi A, Leigh PN, et al. Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients&#x2019; perspectives. J Neurol. 2015;262(4):1002&#x2013;1013. doi: 10.1007/s00415-015-7665-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7665-z</ArticleId><ArticleId IdType="pubmed">25683760</ArticleId></ArticleIdList></Reference><Reference><Citation>Alencar MA, Monique I, Hil&#xe1;rio SM, Ferreira M, Rangel DA, Abdo JS et al (2021) Quality of life, disability, and clinical variables in amyotrophic lateral sclerosis. 1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">34932653</ArticleId></ArticleIdList></Reference><Reference><Citation>Young C, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, et al. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener [Internet]. 2021;0(0):1&#x2013;9. doi: 10.1080/21678421.2021.1990343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1990343</ArticleId><ArticleId IdType="pubmed">34709092</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushton DJ, Andres PL, Allred P, Baloh RH, Svendsen CN. Patients with ALS show highly correlated progression rates in left and right limb muscles. Neurology. 2017;89(2):196&#x2013;206. doi: 10.1212/WNL.0000000000004105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004105</ArticleId><ArticleId IdType="pmc">PMC5501935</ArticleId><ArticleId IdType="pubmed">28600459</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal NA, Berry JD, Windebank A, Staff NP, Maragakis NJ, van den Berg LH, et al. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve. 2020;62(2):156&#x2013;166. doi: 10.1002/mus.26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33(1):127&#x2013;132. doi: 10.1002/mus.20450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20450</ArticleId><ArticleId IdType="pubmed">16258948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakers JNE, van den Berg LH, Ajeks TG, Holleman MJ, Verhoeven J, Beelen A, et al. Portable fixed dynamometry: towards remote muscle strength measurements in patients with motor neuron disease. J Neurol [Internet]. 2021;268(5):1738&#x2013;1746. doi: 10.1007/s00415-020-10366-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10366-9</ArticleId><ArticleId IdType="pmc">PMC8068646</ArticleId><ArticleId IdType="pubmed">33355879</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk RPA, Eijkemans MJC, Ferguson TA, Nikolakopoulos S, Veldink JH, Van Den Berg LH. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. J Neurol Neurosurg Psychiatry. 2018;89(2):156&#x2013;161. doi: 10.1136/jnnp-2017-317077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317077</ArticleId><ArticleId IdType="pmc">PMC5800333</ArticleId><ArticleId IdType="pubmed">29084868</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdom CJ, Janse van Mantgem MR, van Eijk RPA, Howe SL, van den Berg LH, McCombe PA, et al. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2021;28(11):3615&#x2013;3625. doi: 10.1111/ene.15003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15003</ArticleId><ArticleId IdType="pubmed">34216521</ArticleId></ArticleIdList></Reference><Reference><Citation>Geronimo A, Simmons Z. Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20(5&#x2013;6):348&#x2013;355. doi: 10.1080/21678421.2019.1587633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1587633</ArticleId><ArticleId IdType="pubmed">30957547</ArticleId></ArticleIdList></Reference><Reference><Citation>Tattersall R, Carty S, Meldrum D, Hardiman O, Murray D. The patient&#x2019;s perspective of remote respiratory assessments during the COVID-19 pandemic. Amyotroph Lateral Scler Front Degener Internet. 2021;0(0):1&#x2013;5. doi: 10.1080/21678421.2021.1920982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1920982</ArticleId><ArticleId IdType="pubmed">34092157</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Rudnicki SA, Lechtzin N, Cockroft B, Malik FI, Wolff AA, et al. Correlation between slow vital capacity measured in the home and in the clinic for patients with amyotrophic lateral sclerosis. Neurology. 2019;92(15 supplement):P4.4-002.</Citation></Reference><Reference><Citation>Helleman J, Kruitwagen-van Reenen ET, Bakers J, Kruithof WJ, van Groenestijn AC, Jaspers Focks RJH, et al. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases. J Neurol [Internet]. 2020 doi: 10.1007/s00415-020-10003-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10003-5</ArticleId><ArticleId IdType="pmc">PMC7578163</ArticleId><ArticleId IdType="pubmed">32577867</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Bakers JNE, Pirard E, van den Berg LH, Visser-Meily JMA, Beelen A. Home-monitoring of vital capacity in people with a motor neuron disease. J Neurol [Internet]. 2022 doi: 10.1007/s00415-022-10996-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-10996-1</ArticleId><ArticleId IdType="pmc">PMC9217878</ArticleId><ArticleId IdType="pubmed">35129626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Ramos R, Aguilera A, Garcia F, Miramontes-Gomez J, Pathak LE, Figueroa CA, et al. Conducting internet-based visits for onboarding populations with limited digital literacy to an mhealth intervention: Development of a patient-centered approach. JMIR Form Res. 2021;5(4):e25299. doi: 10.2196/25299.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25299</ArticleId><ArticleId IdType="pmc">PMC8086779</ArticleId><ArticleId IdType="pubmed">33872184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri SS, Avila-Garcia P, Cemballi AG, Sarkar U, Aguilera A, Lyles CR. Assessing mobile phone digital literacy and engagement in user-centered design in a diverse, safety-net population: Mixed methods study. JMIR mHealth uHealth. 2019;7(8):1&#x2013;11. doi: 10.2196/14250.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14250</ArticleId><ArticleId IdType="pmc">PMC6740160</ArticleId><ArticleId IdType="pubmed">31469083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>